https://orcid.org/0000-0002-3097-1911
Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Qing She, Yuanyuan Chen, Hong Liu, Jichao Tan & Youhuai Li. (2022) A high level of the long non-coding RNA MCF2L-AS1 is associated with poor prognosis in breast cancer and MCF2L-AS1 activates YAP transcriptional activity to enhance breast cancer proliferation and metastasis. Bioengineered 13:5, pages 13437-13451.
Read now
Read now
Dongsheng Li, Lin Lu, Miaomiao Liu & Jufeng Sun. (2022) Inhibition of long noncoding RNA cancer susceptibility candidate 7 attenuates hepatocellular carcinoma development by targeting microRNA-30a-5p. Bioengineered 13:4, pages 11296-11308.
Read now
Read now
Hao Jia, Wei Sun, Xiangbo Li & Wenhao Xu. (2022) Melatonin promotes apoptosis of thyroid cancer cells via regulating the signaling of microRNA-21 (miR-21) and microRNA-30e (miR-30e). Bioengineered 13:4, pages 9588-9601.
Read now
Read now
Jun Fang, Gaohui Jiang, Weiguo Mao, Lili Huang, Chen Huang, Shanshan Wang, Huimin Xue, Jing Ke & Qichao Ni. (2022) Up-regulation of long noncoding RNA MBNL1-AS1 suppresses breast cancer progression by modulating miR-423-5p/CREBZF axis. Bioengineered 13:2, pages 3707-3723.
Read now
Read now
Xinhua Xi, Zhengbo Hu, Qiang Wu, Konghe Hu, Zhengguo Cao, Jun Zhou, Junjian Liao, Zhipeng Zhang, Yongyu Hu, Xueren Zhong & Yongzheng Bao. (2022) High expression of small nucleolar RNA host gene 3 predicts poor prognosis and promotes bone metastasis in prostate cancer by activating transforming growth factor-beta signaling. Bioengineered 13:1, pages 1895-1907.
Read now
Read now
Articles from other publishers (8)
Shu Yang, Xiaomin Wang, Xintong Zhou, Lin Hou, Jibiao Wu, Wenfeng Zhang, Huayao Li, Chundi Gao & Changgang Sun. (2023) ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies. Biomedicine & Pharmacotherapy 162, pages 114698.
Crossref
Crossref
Qing-Bo Lu, Yi Ding, Xiao Fu, Hai-Jian Sun & Ji-Ru Zhang. (2023) Hydrogen sulfide in health and diseases: cross talk with noncoding RNAs. American Journal of Physiology-Cell Physiology 324:4, pages C856-C877.
Crossref
Crossref
Fei Liu, Qian-Wen Xiong, Jin-Hu Wang & Wan-Xin Peng. (2023) Roles of lncRNAs in childhood cancer: Current landscape and future perspectives. Frontiers in Oncology 13.
Crossref
Crossref
Qiang Zhang, Chuanchi Wang, Yan Yang, Ruihan Xu & Ziyun Li. (2023) LncRNA and its role in gastric cancer immunotherapy. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Luling Wang & Xing Liu. (2023) An oxidative stress-related signature for predicting the prognosis of liver cancer. Frontiers in Genetics 13.
Crossref
Crossref
Mehrdad Hashemi, Motahare Sadat Ayat Mirdamadi, Yasmin Talebi, Nasrin Khaniabad, Gooya Banaei, Pouria Daneii, Sadaf Gholami, Amin Ghorbani, Alireza Tavakolpournegari, Zoheir Mohammadian Farsani, Ali Zarrabi, Noushin Nabavi, Mohammad Arad Zandieh, Mohsen Rashidi, Afshin Taheriazam, Maliheh Entezari & Haroon Khan. (2023) Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents. Pharmacological Research 187, pages 106568.
Crossref
Crossref
Honghao Yu, Wenchang Lv, Yufang Tan, Xiao He, Yiping Wu, Min Wu & Qi Zhang. (2022) Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients. Journal of Translational Medicine 20:1.
Crossref
Crossref
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, Shayan Fallah, Arezoo Sanaei, Elahe Sadat Hejazi, Amirabbas Kakavand, Shamin Rezaei, Hajar Heidari, Mitra Behroozaghdam, Salman Daneshi, Shokooh Salimimoghadam, Sepideh Mirzaei, Mehrdad Hashemi & Saeed Samarghandian. (2022) LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions. Biomedicine & Pharmacotherapy 154, pages 113609.
Crossref
Crossref